Tea volumes declined year-on-year for the first time in a long period, impacted by price inflation and demand softness.
TATA CONSUMER PRODUCTS LIMITED — Q2 FY25
Tata Consumer Products reported a mixed Q2 FY25 with consolidated revenue up 13% to INR 4,200 crore, but EBITDA margin contracted 30 bps to 14.9% due to sharp tea cost inflation (~30% YoY).
Financial stats pending filing verification
2-Minute Summary
Tata Consumer Products reported a mixed Q2 FY25 with consolidated revenue up 13% to INR 4,200 crore, but EBITDA margin contracted 30 bps to 14.9% due to sharp tea cost inflation (~30% YoY). India beverages revenue grew only 3% with tea volumes declining, while India foods grew 29% (organic 9%, volume 1%). International business continued strong with 7% growth and margin expansion. Growth businesses (NourishCo, acquisitions) grew 15%, below the 30% target, impacted by competitive pricing in ready-to-drink. Management expects recovery in NourishCo and continued momentum in Capital Foods and Organic India. Key risk: if competitive intensity prevents full pass-through of tea cost inflation, margins could remain under pressure.
टाटा कंज्यूमर प्रोडक्ट्स का Q2 FY25 का नतीजा मिला-जुला रहा। कंपनी की कुल आय 13% बढ़कर 4,200 करोड़ रुपये हो गई, लेकिन मुनाफा मार्जिन 0.30% घटकर 14.9% रह गया। इसकी वजह चाय की लागत में 30% की भारी बढ़ोतरी है। भारत में पेय पदार्थों की बिक्री सिर्फ 3% बढ़ी और चाय की बिक्री घट गई। वहीं, खाद्य कारोबार 29% बढ़ा। अंतरराष्ट्रीय कारोबार 7% बढ़ा और मुनाफा भी सुधरा। नए कारोबार (जैसे नूरिशको) 15% बढ़े, जो 30% के लक्ष्य से कम है। कंपनी को उम्मीद है कि नूरिशको जल्द सुधरेगा। लेकिन अगर चाय की बढ़ी लागत पूरी तरह ग्राहकों पर नहीं डाली गई, तो मुनाफा दबाव में रहेगा।
Key Numbers
Tata Salt gained 150 basis points market share on a moving annual total basis, reflecting strong brand execution.
Tata Starbucks added 90 stores in the last 12 months, now present in 70 cities, but same-store sales turned negative.
Capital Foods distribution expanded from 250,000 to 500,000 outlets post-acquisition, driving quarter-on-quarter growth of 25%.
What Changed vs Last Quarter
After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter.
The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.
Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics.
Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.
Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.
Management committed to completing the integration of Organic India within 100 days from the April 16 closure, and is on track.
Integration of Capital Foods, including channel inventory cleanup, is complete and run rate is trending as expected.
The rights issue, expected to close on August 19, will be used to repay short-term bridge financing of INR 3,000 crore raised for acquisitions.
Tea input costs are up ~30% YoY, but competitive intensity has limited price increases, pressuring India branded margins. Management indicated they will not sacrifice market share for profitability.
Record high coffee prices are causing demand stress in the non-branded solubles business, which could lead to lower profitability as inventory advantages fade.
Analyst raised concern about weak demand at Starbucks and across FMCG. Management acknowledged urban stress due to food inflation and delayed government spending, with same-store sales negative.
Tata Gluco+ lost competitiveness due to delayed price re-indexing versus peers and new entrants like Campa Cola, leading to a 30% premium to competitors. Corrective actions taken but recovery uncertain.
North Indian tea prices are up 15-20% and coffee prices (Robusta) up ~50% from two quarters ago, which could pressure margins if not passed through.
NourishCo revenue grew only 7% due to intense summer impacting out-of-home consumption and delayed tactical pricing actions, raising concerns about the business's resilience.
Organic India deal closed on April 16, and inventory consolidation took longer than expected, potentially impacting near-term revenue and margins.
Quarterly amortization of INR 55 crore from acquisitions and higher interest costs from bridge financing are depressing reported PAT, with no near-term relief expected.
🤫 Topics management stopped discussing
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
Management reiterated commitment to grow the growth businesses (including acquisitions) from 20% to 30% of the India portfolio, with these businesses growing at 30% CAGR.
Mentioned in Q1 FY25, Q3 FY24, Q4 FY24
Management committed to completing the integration of Organic India within 100 days from the April 16 closure, and is on track.
Mentioned in Q3 FY24, Q4 FY24
Simultaneous integration of Capital Foods and Organic India within 100 days each could strain resources and execution.
Mentioned in Q2 FY24, Q3 FY24
Management remains confident of delivering INR 900-1,000 crore for NourishCo in FY24, despite Q3 being seasonally weak.
Mentioned in Q2 FY24, Q4 FY24
NourishCo missed its INR 900-1000 crore guidance, ending at INR 825 crore, partly due to delayed summer. Size may become a growth constraint.
Management Guidance
NourishCo to return to 25-30% growth by end of Q3 FY25
After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter.
Management guidance growthInnovation to sales ratio to exceed 5% for full year FY25
The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%.
Management guidance growthFurther tea price increases expected
Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics.
Management guidance revenueStructural margin improvement over the long term
Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.
Management guidance marginsKey Risks
Tea cost inflation not fully passed through
Tea input costs are up ~30% YoY, but competitive intensity has limited price increases, pressuring India branded margins. Management indicated they will not sacrifice market share for profitability.
high · management_commentaryDemand destruction in coffee solubles
Record high coffee prices are causing demand stress in the non-branded solubles business, which could lead to lower profitability as inventory advantages fade.
medium · management_commentaryUrban consumption slowdown impacting Starbucks and broader portfolio
Analyst raised concern about weak demand at Starbucks and across FMCG. Management acknowledged urban stress due to food inflation and delayed government spending, with same-store sales negative.
medium · analyst_questionCompetitive pricing pressure in ready-to-drink
Tata Gluco+ lost competitiveness due to delayed price re-indexing versus peers and new entrants like Campa Cola, leading to a 30% premium to competitors. Corrective actions taken but recovery uncertain.
medium · analyst_questionNotable Quotes
If one can play the game, two can play the game. So if the game is saying that they will outlast or they will hold on for longer and put stress on the rest of the industry, I would just say rest of the industry, minus Tata Consumer is who's going to feel the stress. I will not forgo market share, because gaining back market share in the longer term is a far more painful and far more expensive proposition.
I am here for the long haul, and I will not forego market share. We have gone in there, we've made the corrective actions, we've taken down price, and that's why I emphasize the impact was on Tata Gluco+ only.
In the long run, of course, we'll be looking at structurally improving our margin. Also, we have now tailwinds from the new acquisitions that we made, which comes in at a significant accretion to overall margin play.
Frequently Asked Questions
What was TATA CONSUMER PRODUCTS's revenue in Q2 FY25?
TATA CONSUMER PRODUCTS reported revenue of ₹4,200 Cr in Q2 FY25, representing a +13% change compared to the same quarter last year.
What guidance did TATA CONSUMER PRODUCTS management give for FY26?
NourishCo to return to 25-30% growth by end of Q3 FY25: After re-indexing pricing on Tata Gluco+, management expects the ready-to-drink business to resume its normative growth trajectory by the end of the current quarter. Innovation to sales ratio to exceed 5% for full year FY25: The company is on track to deliver innovation as a percentage of sales above 5% for the full year, with Q2 at 4.1%. Further tea price increases expected: Staggered price increases have been actioned and more are planned to mitigate the 30% tea cost inflation, though full pass-through depends on competitive dynamics. Structural margin improvement over the long term: Management reiterated commitment to improving EBITDA margins year-on-year, supported by new acquisitions and operating leverage, though near-term tea cost volatility is a watch-out.
What are the key risks for TATA CONSUMER PRODUCTS in FY26?
Key risks include Tea cost inflation not fully passed through — Tea input costs are up ~30% YoY, but competitive intensity has limited price increases, pressuring India branded margins. Management indicated they will not sacrifice market share for profitability.; Demand destruction in coffee solubles — Record high coffee prices are causing demand stress in the non-branded solubles business, which could lead to lower profitability as inventory advantages fade.; Urban consumption slowdown impacting Starbucks and broader portfolio — Analyst raised concern about weak demand at Starbucks and across FMCG. Management acknowledged urban stress due to food inflation and delayed government spending, with same-store sales negative.; Competitive pricing pressure in ready-to-drink — Tata Gluco+ lost competitiveness due to delayed price re-indexing versus peers and new entrants like Campa Cola, leading to a 30% premium to competitors. Corrective actions taken but recovery uncertain..
Did TATA CONSUMER PRODUCTS meet its previous quarter's guidance?
Of 3 tracked promises, management 0 met, 0 close, 3 missed.
Where can I read the full TATA CONSUMER PRODUCTS Q2 FY25 concall transcript?
The full earnings conference call transcript or source release is available on the linked source material. This page provides an AI-generated summary with filing verification status shown on the financial stats.